# Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy

> **NCT00222443** · PHASE1 · COMPLETED · sponsor: **University of Oklahoma** · enrollment: 40 (—)

## Conditions studied

- Lymphomas
- Tumors

## Interventions

- **DRUG:** Irinotecan

## Key facts

- **NCT ID:** NCT00222443
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 40 (—)
- **Last updated:** 2008-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00222443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00222443, "Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00222443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*